Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01194973
What this trial is testing

An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome

Who this might be right for
Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc. 44
Large-scale testing (Phase 3)Study completedNCT05422365
What this trial is testing

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia
Biopharma Plasma LLC 32
Large-scale testing (Phase 3)Not Yet RecruitingNCT06925698
What this trial is testing

Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease

Who this might be right for
Behcet DiseaseBehcet Disease and Vascular InvolvementDeep Venous Thromboses+1 more
Marmara University 110
Early research (Phase 1)Study completedNCT03126695
What this trial is testing

Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered

Who this might be right for
Sickle Cell Disease
AstraZeneca 44
Early research (Phase 1)Study completedNCT03603132
What this trial is testing

Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics

Who this might be right for
Immune Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT01988506
What this trial is testing

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisSystemic Lupus Erythematosus+11 more
Assistance Publique - Hôpitaux de Paris 81
Large-scale testing (Phase 3)Active Not RecruitingNCT04812925
What this trial is testing

Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
argenx 173
Large-scale testing (Phase 3)Looking for participantsNCT05935215
What this trial is testing

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 50
Not applicableUnknownNCT06098378
What this trial is testing

Study of Patients With Thrombotic Microangiopathy Associated With Mitomycin C, Treated or Not With Eculizumab

Who this might be right for
Thrombotic Microangiopathies
University Hospital, Strasbourg, France 30
Not applicableUnknownNCT03368313
What this trial is testing

Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis

Who this might be right for
Deep Vein ThrombosisPost Thrombotic Syndrome
Pró Circulação® 120
Testing effectiveness (Phase 2)Study completedNCT00625443
What this trial is testing

Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Eisai Inc. 53
Not applicableUnknownNCT05785468
What this trial is testing

A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1
Not applicableStudy completedNCT05222750
What this trial is testing

Epidemiology of Thrombotic Thrombocytopenia Syndrome in Integrated Health-care Database in England

Who this might be right for
COVID-19
AstraZeneca 41,200,246
Not applicableNot Yet RecruitingNCT07680010
What this trial is testing

Modeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile Lupus

Who this might be right for
Immune Thrombocytopenic Purpura ( ITP )Systemic Lupus Erythematosus (SLE)
University Hospital, Bordeaux 105
Testing effectiveness (Phase 2)UnknownNCT02757196
What this trial is testing

Treatment of ITP With Rituximab and / or Accutane

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 112
Not applicableNot Yet RecruitingNCT07405749
What this trial is testing

Cirrhotic and Non-cirrhotic Patients With Clinically Significant Portal Hypertension

Who this might be right for
Cirrhosis, LiverPortal HypertensionClinically Significant Portal Hypertension(CSPH)+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2,500
Not applicableLooking for participantsNCT07059026
What this trial is testing

Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients

Who this might be right for
Thrombotic Microangiopathy
ITAC (Instituto de Trasplantes y Alta Complejidad) 200
Testing effectiveness (Phase 2)Study completedNCT00718692
What this trial is testing

Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenic Purpura
Symphogen A/S 61
Not applicableNot Yet RecruitingNCT07473284
What this trial is testing

Incidence and Characteristic of CRT Persistent After Catheter Extraction in ICU Patients

Who this might be right for
Catheter ThrombosisPost Thrombotic SyndromePulmonary Embolism (Diagnosis)
Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. 300
Post-approval studies (Phase 4)WithdrawnNCT04411316
What this trial is testing

Catheter-directed Thrombolysis Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis

Who this might be right for
Deep Venous ThrombosisPost Thrombotic Syndrome
University of Toledo Health Science Campus
Next Page